How Sleep Loss Rewires Your Brain for Food Cravings
There is a reason why this cycle repeats itself so predictably. Research shows that insufficient sleep disrupts hunger signals, weakens self-control, impairs glucose metabolism and increases your risk of weight gain. These changes can occur rapidly, even after a single night of poor sleep, and can become more harmful over time if left unaddressed.
As a neurologist specializing in sleep science and its impact on health, I know that sleep deprivation affects millions. According to the Centers for Disease Control and Prevention, more than one-third of U.S. adults regularly get less than seven hours of sleep per night. Nearly three-quarters of adolescents fall short of the recommended eight to 10 hours of sleep during the school week.
While anyone can suffer from sleep loss, essential workers and first responders, including nurses, firefighters and emergency personnel, are especially vulnerable due to night shifts and rotating schedules. These patterns disrupt the body's internal clock and are linked to increased cravings, poor eating habits, and elevated risks for obesity and metabolic disease. Fortunately, even a few nights of consistent, high-quality sleep can help rebalance key systems and start to reverse some of these effects.
Your body regulates hunger through a hormonal feedback loop involving two key hormones.
Ghrelin, produced primarily in the stomach, signals that you're hungry, while leptin, which is produced in the fat cells, tells your brain that you're full. Even one night of restricted sleep increases the release of ghrelin and decreases leptin, which leads to greater hunger and reduced satisfaction after eating. This shift is driven by changes in how the body regulates hunger and stress. Your brain becomes less responsive to fullness signals, while at the same time ramping up stress hormones that can increase cravings and appetite.
These changes are not subtle. In controlled lab studies, healthy adults reported increased hunger and stronger cravings for calorie-dense foods after sleeping only four to five hours. The effect worsens with ongoing sleep deficits, which can lead to a chronically elevated appetite.
Sleep loss changes how your brain evaluates food.
Imaging studies show that after just one night of sleep deprivation, the prefrontal cortex, which is responsible for decision-making and impulse control, has reduced activity. At the same time, reward-related areas such as the amygdala and the nucleus accumbens, a part of the brain that drives motivation and reward-seeking, become more reactive to tempting food cues.
In simple terms, your brain becomes more tempted by junk food and less capable of resisting it. Participants in sleep deprivation studies not only rated high-calorie foods as more desirable but were also more likely to choose them, regardless of how hungry they actually felt.
Sleep is also critical for blood sugar control.
When you're well-rested, your body efficiently uses insulin to move sugar out of your bloodstream and into your cells for energy. But even one night of partial sleep can reduce insulin sensitivity by up to 25%, leaving more sugar circulating in your blood.
If your body can't process sugar effectively, it's more likely to convert it into fat. This contributes to weight gain, especially around the abdomen. Over time, poor sleep is associated with higher risk for Type 2 diabetes and metabolic syndrome, a group of health issues such as high blood pressure, belly fat and high blood sugar that raise the risk for heart disease and diabetes.
On top of this, sleep loss raises cortisol, your body's main stress hormone. Elevated cortisol encourages fat storage, especially in the abdominal region, and can further disrupt appetite regulation.
In a culture that glorifies hustle and late nights, sleep is often treated as optional. But your body doesn't see it that way. Sleep is not downtime. It is active and essential repair. It is when your brain recalibrates hunger and reward signals, your hormones reset, and your metabolism stabilizes.
Just one or two nights of quality sleep can begin to undo the damage from prior sleep loss and restore your body's natural balance.
So the next time you find yourself reaching for junk food after a short night, recognize that your biology is not failing you. It is reacting to stress and fatigue. The most effective way to restore balance isn't a crash diet or caffeine. It's sleep.
Sleep is not a luxury. It is your most powerful tool for appetite control, energy regulation and long-term health.
This article is republished from The Conversation under a Creative Commons license. Read the original article.
The post How Sleep Loss Rewires Your Brain for Food Cravings appeared first on Katie Couric Media.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
eHealth (EHTH) Q2 Earnings Report Preview: What To Look For
Online health insurance comparison site eHealth (NASDAQ:EHTH) will be reporting results this Wednesday morning. Here's what to expect. eHealth beat analysts' revenue expectations by 13.4% last quarter, reporting revenues of $113.1 million, up 21.7% year on year. It was an exceptional quarter for the company, with a solid beat of analysts' EBITDA estimates and full-year EBITDA guidance exceeding analysts' expectations. It reported 1.16 million users, down 1.8% year on year. Is eHealth a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting eHealth's revenue to decline 29.5% year on year to $46.41 million, a further deceleration from the 1.4% decrease it recorded in the same quarter last year. Adjusted loss is expected to come in at -$1.25 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. eHealth has a history of exceeding Wall Street's expectations, beating revenue estimates every single time over the past two years by 13.1% on average. Looking at eHealth's peers in the online marketplace segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Shutterstock delivered year-on-year revenue growth of 21.3%, beating analysts' expectations by 7.5%, and EverQuote reported revenues up 33.7%, in line with consensus estimates. Shutterstock's stock price was unchanged following the results. Read our full analysis of Shutterstock's results here and EverQuote's results here. Investors in the online marketplace segment have had steady hands going into earnings, with share prices up 1.5% on average over the last month. eHealth is down 22.5% during the same time and is heading into earnings with an average analyst price target of $10 (compared to the current share price of $3.21). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Long Covid Patients Can Sign up for Remote Clinical Trial Notification, Announces CareEvolution
At-home participation in a study by Scripps Research and Schmidt Initiative for Long Covid powered by CareEvolution's MyDataHelps® platform ANN ARBOR, Mich., August 05, 2025--(BUSINESS WIRE)--Long Covid patients around the U.S. looking to participate in a clinical trial from home can sign up to be notified when an upcoming study conducted by scientists at Scripps Research and supported by the Schmidt Initiative for Long Covid (SILC) opens. Patients can sign up on the Long Covid Treatment Trial (LoCITT) website. The upcoming study, powered by the MyDataHelps platform from CareEvolution, is a fully remote clinical trial investigating the efficacy of a repurposed drug for treating Long COVID. It will enroll 1,000 Long Covid patients from across the U.S. The app-based study enables participants to enroll and participate in all trial activities without having to visit a trial clinic. "Decentralized trials broaden reach, speed timelines and yield richer real-world evidence," said Vik Kheterpal, MD, a principal at CareEvolution. "LoCITT will help advance how efficiently we can run trials as we seek treatments for complex, heterogeneous conditions like Long Covid." Long Covid, which has affected the lives of 400 million people worldwide and costs the global economy an estimated $1 trillion per year, can often cause symptoms that make mobility and travel challenging for patients who want to participate in trials. The forthcoming Scripps Research-led trial will rely on the LoCITT platform to enroll patients, distribute drug candidates and placebos, as well as collect and evaluate trial data. "For people with severe Long Covid, travel can be dangerous," said Julia Moore Vogel, senior program director at the Scripps Research Translational Institute. "LoCITT enables even patients with the most severe symptoms to join the search for answers." Moore Vogel is co-principal investigator of the study alongside Scripps Research executive vice president Eric Topol. Remote trials, which eliminate the need for patients to report to clinics, enable easier and broader participation. Conducting a Long Covid trial remotely will also allow more representative cohorts—potentially leading to more generalizable findings. "We need aggressive, rapid efforts to turn the tide on this very difficult condition for all the patients who struggle with it," said John Redd, CEO of SILC. "We're hopeful that a remote trial will help us find effective treatments more quickly." CareEvolution adapted its existing MyDataHelps decentralized clinical trial platform specifically for the LoCITT trial, with the potential for it to be used by other research efforts. The platform will allow for patients to be screened, enrolled and randomized more swiftly. Potential treatments and placebos will be mailed directly to the participant's home, along with wearable devices and other technologies to collect patient data. CareEvolution's user-friendly platform allows patients to check their eligibility, provide consent electronically and respond to baseline and ongoing surveys about their symptoms. Patients selected for the study will receive wrist devices to monitor their heart rates, activity and sleep, potentially enabling the development of digital biomarkers for Long Covid and related conditions like myalgic encephalomyelitis (ME), which can cause debilitating fatigue, and postural orthostatic tachycardia syndrome (POTS), which can cause dizziness, fatigue and a rapid heart rate upon standing up. The data from the devices will be uploaded to LoCITT. Prospective participants who are 18 years of age or older and who believe they have Long Covid can sign up at to be notified when the Scripps clinical trial opens. About CareEvolution We Connect Healthcare. MyDataHelps®, our digital clinical trials platform, accelerates healthcare innovation by empowering researchers to configure and launch studies in hours. We enable anyone, anywhere to be able to participate in research using participant centric design that integrates surveys, wearable and sensor data, EHR connectivity, and participant engagement tools to generate robust real-world longitudinal data. Trusted by over 2.5 million participants enrolled in longitudinal initiatives sponsored by health systems, academic institutions, life science companies, foundations, and public health agencies, CareEvolution advances precision health and helps close critical gaps in our collective understanding of complex conditions. For more information please visit About the Schmidt Initiative for Long Covid The Schmidt Initiative for Long Covid (SILC) advances clinical care for Long Covid patients globally. The nonprofit organization, founded in 2023 by philanthropists Eric and Wendy Schmidt, works to raise the level of Long Covid care and understanding around the world, connecting specialists and primary care providers to support patients and share knowledge virtually, in real time. For more information, visit About Scripps Research Scripps Research is an independent, nonprofit biomedical institute ranked one of the most influential in the world for its impact on innovation by Nature Index. We are advancing human health through profound discoveries that address pressing medical concerns around the globe. Our drug discovery and development division, Calibr-Skaggs, works hand-in-hand with scientists across disciplines to bring new medicines to patients as quickly and efficiently as possible, while teams at Scripps Research Translational Institute harness genomics, digital medicine and cutting-edge informatics to understand individual health and render more effective healthcare. Scripps Research also trains the next generation of leading scientists at our Skaggs Graduate School, consistently named among the top 10 US programs for chemistry and biological sciences. Learn more at View source version on Contacts CareEvolutionpr@ Swati Pandey, SILCspandey@ Anna Andersen, Scripps Researchaanders@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
These 5 Surprising Carbs Help You Stay Full and Stick to a Calorie Deficit, Trainer Says
These 5 Surprising Carbs Help You Stay Full and Stick to a Calorie Deficit, Trainer Says originally appeared on Men's Fitness. Carbs are not the root of all evil. But when you're in a calorie deficit, they can feel off-limits. The truth is, carbs are the body's main source of fuel. They power our heavy lifting days, energize outdoor runs, and sustain us through everyday life. Still, some carb-heavy foods like bread can be calorie-dense and feel like a trap when you're trying to cut back. Trainer Dan Go shared five low-calorie carb sources that actually help keep you full while you're in a Carbs Potatoes "Potatoes are low in calories, high in fiber—especially with the skin. This makes them incredibly filling, and also their resistant starch and high water content helps you feel satisfied longer," Go says. Blueberries Blueberries may not be the first food that comes to mind when thinking about carbs. But, with their rich fiber and water content, they're a low-calorie carb that's highly satiating. The fiber in blueberries also slows digestion, which keeps you full and helps stabilize blood sugar. Lentils Lentils are small, but their fiber content is mighty. Along with its carb content, they're also a great source of plant protein, high in satiety. Broccoli "The reason I love broccoli is because it's one of the perfect foods to volumize your meals, because it contains a lot of fiber, a lot of water, and it helps you keep full while giving you an incredible nutrient profile," Go says. Rich in vitamin C, K, and folate, eating broccoli helps support your metabolism and digestion. Apples Go calls apples "nature's appetite suppressant." If you need a sweet treat during your calorie deficit, lean on apples. They're high in fiber and low in calories, helping you curb hunger and reduce snacking. Apples are also rich in 5 Surprising Carbs Help You Stay Full and Stick to a Calorie Deficit, Trainer Says first appeared on Men's Fitness on Jul 10, 2025 This story was originally reported by Men's Fitness on Jul 10, 2025, where it first appeared. Solve the daily Crossword